KZ Precision Corporation (KOSDAQ:036560)
10,890
-160 (-1.45%)
At close: Oct 29, 2026
KZ Precision Revenue
KZ Precision had revenue of 34.27B KRW in the quarter ending June 30, 2026, with 6.65% growth. This brings the company's total for the last twelve months to 113.90B, up 5.84% year-over-year. In the year 2025, KZ Precision had annual revenue of 110.51B, down -1.95%. That makes KZ Precision the 23,874th largest company in the world by revenue and 1,357th in South Korea.
Revenue (ttm)
113.90B
Revenue Growth
+5.84%
P/S Ratio
1.53
Revenue / Employee
448.44M
Employees
254
Market Cap
171.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 110.51B | -2.20B | -1.95% |
| Dec 31, 2024 | 112.71B | -25.99B | -18.74% |
| Dec 31, 2023 | 138.70B | 49.64B | 55.73% |
| Dec 31, 2022 | 89.07B | 10.32B | 13.11% |
| Dec 31, 2021 | 78.74B | -12.10B | -13.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 525.04B |
| iFamilySC | 225.55B |
| Deokyang Energen | 150.00B |
| DAE HWA Pharmaceutical | 148.75B |
| BNC KOREA | 91.19B |
| EMRO., Incorporated. | 83.98B |
| Komelon | 77.65B |
| Vivozon Pharmaceutical | 50.34B |